Progesterone is essential for embryo development during pregnancy, and inadequate levels can increase the risk of miscarriage. In assisted reproduction treatments, monitoring this hormone is key to determining the optimal timing for certain procedures.

Qassay optimizes this process by reducing the wait time for results, allowing healthcare professionals to assess progesterone levels in real-time. This facilitates immediate clinical decision-making, such as adjusting medication or planning interventions based on each patient’s hormonal needs.

Beta-human chorionic gonadotropin (B-hCG) is a hormone produced during pregnancy that is essential for the development of the embryo. Measurement of B-hCG is the basis for confirming a pregnancy and can be detected as early as 6 days after fertilization.

In in vitro fertilization (IVF) processes or ovarian stimulation treatments, monitoring B-hCG is crucial to determine the success of the treatment. B-hCG levels can help assess the health of the pregnancy in its early stages. An increase in B-hCG levels indicates a viable pregnancy, while low or declining levels may signal problems such as a miscarriage or an ectopic pregnancy.

Levels of luteinizing hormone (LH) increase dramatically just before ovulation in a phenomenon known as the “LH surge.” This increase is a key indicator that a woman is in her fertile window, which can be crucial for those trying to conceive. 

Analyzing LH levels, along with other hormones such as FSH (follicle-stimulating hormone), can provide insights into the causes of infertility and assist in selecting appropriate treatments. In treatments such as in vitro fertilization (IVF), LH levels are monitored to adjust hormonal medication and optimize the chances of success.

The Antimüllerian Hormone (AMH) test allows the estimation of a woman’s ovarian reserve, meaning the number of available fertile ovaries, which is essential for achieving pregnancy.

One of the main advantages of AMH compared to other ovarian reserve indicators is that it can be measured at any point during the menstrual cycle. This hormone is also a highly accurate marker for detecting ovarian abnormalities, as abnormal AMH levels are associated with polycystic ovary syndrome, premature ovarian failure, or early menopause.

The reference values for Anti-Müllerian hormone in the female fertility test are as follows:

– Good ovarian reserve: above 3 ng/ml.

– Normal ovarian reserve: between 1.2 and 3 ng/ml.

– Low ovarian reserve: below 1.1 ng/ml.

FSH is crucial for evaluating the quantity and quality of available eggs in the ovaries. Elevated levels can indicate diminished ovarian reserve, which may reduce the chances of conception, particularly during treatments like in vitro fertilization (IVF).

Monitoring FSH levels at home can help optimize medication dosages during IVF, enhancing ovarian response and minimizing the risk of complications such as ovarian hyperstimulation.

Estradiol is a form of estrogen, a sex hormone primarily produced in the ovaries. It is responsible for developing secondary sexual characteristics, regulating the menstrual cycle, and maintaining pregnancy.

During the menstrual cycle, estradiol levels fluctuate, peaking just before ovulation. Measuring these levels can help determine if a woman is ovulating properly.

In fertility treatments like in vitro fertilization (IVF), estradiol levels are monitored to assess how well the ovaries respond to hormonal stimulation. Adequate estradiol levels can indicate a healthy hormonal environment that may support embryo implantation and pregnancy maintenance.